drugset
drugset / Trial / NCT01497990

Pharmacokinetics Ertapenem Burns

NCT01497990 ↗

Phase 4 Completed 8 enrolled Nantes University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study will examine the pharmacokinetics of ertapenem in ventilated badly (\> 30% SCT) burn patients.

Timeline

Start
2010-01
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule 1 g Intravenous

Indications

No indication recorded.